Advertisement

Case Study 4: Buprenorphine Induction

  • Jungjin KimEmail author
Chapter

Abstract

The case of Stacey is discussed, a 17-year-old female with a severe opioid use disorder who is looking to start buprenorphine. Long-term medication treatment with buprenorphine is an effective and viable option for treating adolescent opioid use disorder. Buprenorphine may be considered safer than other opioid agonist treatments due to its ceiling effect. Ceiling effect refers to plateauing of opioid agonist effects (including respiratory depression) despite dose escalation. While respiratory depression and death may still occur when combined with other drugs (e.g., benzodiazepines), in most cases the benefit of providing effective addiction treatment that incorporates pharmacotherapy exceeds the risks of medication use.

Keywords

Opioid use disorder Buprenorphine Overdose Withdrawal Clinical Opiate Withdrawal Scale Adolescents Young adults 

References

  1. 1.
    Committee on Substance Use and Prevention. Medication-assisted treatment of adolescents with opioid use disorders. Pediatrics. 2016;138(3):e20161893.CrossRefGoogle Scholar
  2. 2.
    Subramanian G, Levy S. Treatment of opioid-dependent adolescents and young adults using sublingual buprenorphine. Providers’ clinical support system for medication assisted treatment. Providence: American Academy of Addiction Psychiatry; 2013.Google Scholar
  3. 3.
    Wesson DR, Ling W. The clinical opiate withdrawal scale (COWS). J Psychoactive Drugs. 2003;35(2):253–9.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Division of Alcohol and Drug AbuseMcLean Hospital/Harvard Medical SchoolBelmontUSA

Personalised recommendations